CSI FOCUS D-HF: Neuromodulation in the management of heart failure and its comorbidities: diabetes, sleep apnea and hypertension
Friday, 5 February 2021
Howard Levin, Coridea, New York, USA
Felix Mahfoud, Saarland University Hospital, Homburg, Germany
The top heart failure target for renal denervation...
- … should be HFpEF >> Michael Böhm
- … should be HFrEF >> Marat Fudim
- … should be arrhythmias >> Marshall Heradien
Phrenic nerve stimulation with the Remede system >> William Abraham
BAROSTIM to treat HFrEF – Approved therapy for an unmet need! >> Jörn Schmitt
Endovascular ablation of the right greater splanchnic nerve >> Horst Sievert
Backbeat >> Daniel Burkhoff
Cardiac contractility modulation - How it works >> Joachim Ehrlich
An endovascular approach to Baroreflex neuromodulation >> Horst Sievert
The webinar was accredited by the European Board for Accreditation in Cardiology (EBAC) with 2 CME credits.
This webinar was supported by:
This session forms part of the CSI Focus D-HF webinar series, providing a
comprehensive overview of devices in heart failure.
View full program here